01/10/2025
3:25 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
10:29 AM | Cytokinetics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
01/07/2025
3:17 PM | Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/06/2025
3:22 PM | Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:23 PM | Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:25 PM | Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
3:25 PM | Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
01/06/2025
3:27 PM | Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
6:23 PM | Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:38 PM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2024
3:13 PM | Cytokinetics (Subject)
WIERENGA WENDALL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024
9:17 AM | Cytokinetics (Subject)
HENDERSON JOHN T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
4:42 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:30 PM | Cytokinetics (Issuer)
Lee Sung (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:32 PM | Cytokinetics (Issuer)
Wong Robert (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:22 PM | Callos Andrew (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:28 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
5:46 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
3:01 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
6:05 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
4:38 PM | Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
3:10 PM | Cytokinetics (Subject)
WIERENGA WENDALL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024
5:02 AM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
4:04 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
8:55 AM | Cytokinetics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
11/04/2024
4:45 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
10:17 AM | Cytokinetics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/01/2024
3:43 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
3:45 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2024
3:49 PM | Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
3:12 PM | Cytokinetics (Subject)
WIERENGA WENDALL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
4:04 PM | BlackRock, Inc. (Filed by)
Cytokinetics (Subject)
| Form SC 13G/A | |
10/16/2024
5:45 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
3:32 PM | Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/09/2024
3:08 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
4:24 PM | Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
4:25 PM | Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
4:26 PM | Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
4:27 PM | Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
4:28 PM | Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
3:48 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
09/30/2024
5:56 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
3:15 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:29 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
4:06 PM | Cytokinetics (Issuer)
Pletcher Brett A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
4:09 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
4:14 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:00 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
3:07 PM | Cytokinetics (Issuer)
Pletcher Brett A (Reporting)
| Form 3/A | |
08/12/2024
4:31 PM | Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
4:32 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
3:21 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
7:06 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:14 PM | Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/31/2024
3:36 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
3:39 PM | Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/29/2024
3:17 PM | Cytokinetics (Subject)
PARSHALL B LYNNE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/23/2024
3:47 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
3:21 PM | Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
4:05 PM | Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2024
3:11 PM | Cytokinetics (Subject)
PARSHALL B LYNNE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
4:24 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2024
5:15 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/09/2024
3:06 PM | Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/08/2024
4:06 PM | Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2024
3:03 PM | Cytokinetics (Subject)
Harrington Robert Arthur (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2024
7:00 PM | Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
7:02 PM | Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
7:04 PM | Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
7:05 PM | Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
7:07 PM | Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
4:12 PM | Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
4:26 PM | Cytokinetics (Subject)
PARSHALL B LYNNE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2024
3:43 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/25/2024
7:04 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:39 PM | Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
4:13 PM | Blum Robert I (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:17 PM | Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:22 PM | Blum Robert I (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
3:24 PM | Cytokinetics (Subject)
PARSHALL B LYNNE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024
4:16 PM | Cytokinetics (Subject)
Malik Fady Ibraham (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
4:08 PM | Bhanji Muna (Reporting)
Cytokinetics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024
4:13 PM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
4:23 PM | Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
9:02 AM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
3:30 PM | Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:36 PM | Cytokinetics (Subject)
PARSHALL B LYNNE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
3:33 PM | Cytokinetics (Issuer)
Wong Robert (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:15 PM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2024
4:59 PM | Cytokinetics (Issuer)
Wysenski Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:00 PM | Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
05/16/2024
5:01 PM | Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:03 PM | Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:04 PM | Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:05 PM | Cytokinetics (Issuer)
Harrington Robert Arthur (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:06 PM | COSTA SANTO J (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:17 PM | Bhanji Muna (Reporting)
Cytokinetics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:00 AM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:05 AM | Cytokinetics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
3:37 PM | Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
